guest ::
| Home > Publications database > Temporal auto-regulation during human PU.1 locus SubTAD formation. > print |
| Home > Publications database > Temporal auto-regulation during human PU.1 locus SubTAD formation. > print |
| 001 | 141106 | ||
| 005 | 20240229105118.0 | ||
| 024 | 7 | _ | |a 10.1182/blood-2018-02-834721 |2 doi |
| 024 | 7 | _ | |a pmid:30315124 |2 pmid |
| 024 | 7 | _ | |a 0006-4971 |2 ISSN |
| 024 | 7 | _ | |a 1079-6533 |2 ISSN |
| 024 | 7 | _ | |a 1528-0020 |2 ISSN |
| 024 | 7 | _ | |a 1938-1336 |2 ISSN |
| 024 | 7 | _ | |a altmetric:49653345 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2018-01640 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Schuetzmann, Daniel |0 0000-0003-4448-6607 |b 0 |
| 245 | _ | _ | |a Temporal auto-regulation during human PU.1 locus SubTAD formation. |
| 260 | _ | _ | |a Stanford, Calif. |c 2018 |b HighWire Press |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1555505259_13138 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Epigenetic control of gene expression occurs within discrete spatial chromosomal units called topologically associating domains (TADs), but the exact spatial requirements of most genes are unknown; this is of particular interest for genes involved in cancer. We therefore applied high-resolution chromosomal conformation capture-sequencing to map the three-dimensional (3D) organization of the human locus encoding the key myeloid transcription factor PU.1 in healthy monocytes and acute myeloid leukemia (AML) cells. We identified a dynamic ~75kb unit (SubTAD) as the genomic region in which spatial interactions between PU.1 gene regulatory elements occur during myeloid differentiation and are interrupted in AML. Within this SubTAD, proper initiation of the spatial chromosomal interactions requires PU.1 auto-regulation and recruitment of the chromatin-adaptor protein LDB1 (LIM domain-binding protein 1). However, once these spatial interactions have occurred, LDB1 stabilizes them independently of PU.1 auto-regulation. Thus, our data support that PU.1 auto-regulates its expression in a hit-and-run manner by initiating stable chromosomal loops that result in a transcriptionally active chromatin architecture. |
| 536 | _ | _ | |a 317 - Translational cancer research (POF3-317) |0 G:(DE-HGF)POF3-317 |c POF3-317 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 700 | 1 | _ | |a Walter, Carolin |b 1 |
| 700 | 1 | _ | |a van Riel, Boet |b 2 |
| 700 | 1 | _ | |a Kruse, Sabrina |0 P:(DE-He78)0d2d2e2cf00b6cd853cb19769ce54aca |b 3 |
| 700 | 1 | _ | |a König, Thorsten |b 4 |
| 700 | 1 | _ | |a Erdmann, Tabea |b 5 |
| 700 | 1 | _ | |a Tönges, Alexander |b 6 |
| 700 | 1 | _ | |a Bindels, Eric |b 7 |
| 700 | 1 | _ | |a Weilemann, Andre |b 8 |
| 700 | 1 | _ | |a Gebhard, Claudia |b 9 |
| 700 | 1 | _ | |a Wethmar, Klaus |b 10 |
| 700 | 1 | _ | |a Perrod, Chiara |b 11 |
| 700 | 1 | _ | |a Minderjahn, Julia |b 12 |
| 700 | 1 | _ | |a Rehli, Michael |b 13 |
| 700 | 1 | _ | |a Delwel, Ruud |b 14 |
| 700 | 1 | _ | |a Lenz, Georg |b 15 |
| 700 | 1 | _ | |a Gröschel, Stefan |b 16 |
| 700 | 1 | _ | |a Dugas, Martin |0 0000-0001-9740-0788 |b 17 |
| 700 | 1 | _ | |a Rosenbauer, Frank |0 0000-0001-7977-9421 |b 18 |
| 773 | _ | _ | |a 10.1182/blood-2018-02-834721 |g p. blood-2018-02-834721 - |0 PERI:(DE-600)1468538-3 |n 22 |p 2643-2655 |t Blood |v 132 |y 2018 |x 0006-4971 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:141106 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)0d2d2e2cf00b6cd853cb19769ce54aca |
| 913 | 1 | _ | |a DE-HGF |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-317 |2 G:(DE-HGF)POF3-300 |v Translational cancer research |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |b Gesundheit |
| 914 | 1 | _ | |y 2018 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b BLOOD : 2017 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a IF >= 15 |0 StatID:(DE-HGF)9915 |2 StatID |b BLOOD : 2017 |
| 920 | 1 | _ | |0 I:(DE-He78)G240-20160331 |k G240 |l Molekulare Leukämogenese |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)L101-20160331 |k L101 |l DKTK Heidelberg |x 1 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)G240-20160331 |
| 980 | _ | _ | |a I:(DE-He78)L101-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|